is contrave a glp-1 medication vs. Wegovy - Difference in Weight Loss, Side Effects & Dosage CONTRAVE - New Obesity Medication

GLP-1 medications cause constipation by slowing gastric emptying and overall gut transit time Macrogol preparations retain water in stool and are recommended for long-term use with GLP-1 therapy Bulk-forming laxatives like ispaghula husk are first-line treatment according to NICE guidance Adequate hydration (1.52 litres daily) is essential when using laxatives with GLP-1 medications Patients should seek medical advice if constipation persists beyond 12 weeks despite treatment Table of Contents Have questions about Wegovy

[16] [18] Ascorbic acid crosses the placenta and is excreted in breast milk

Takes Time to See Results Most people notice real changes in 8 to 12 weeks

According to standard clinical guidance and Omzo's own eligibility framing, licensed clinicians evaluating GLP-1 candidacy typically consider factors like body mass index, medical history, existing conditions (particularly thyroid disease, pancreatitis, or other contraindications for GLP-1 medications), current medications, and personal health goals

At the highest doses, Mounjaro produced an average weight loss of 20.9% of starting body weight compared to 14.9% for Wegovy